More than half of infants insured through Medicaid who were diagnosed with HIV within one year of life did not receive postnatal antiretroviral prophylaxis, according to new findings presented at IDWeek 2024.
More than half of infants insured through Medicaid who were diagnosed with HIV within one year of life did not receive postnatal antiretroviral prophylaxis, according to new findings presented at IDWeek 2024.
A vaccine to prevent mpox is well tolerated and leads to a similar antibody response in adolescents compared to adults, according to new findings presented at IDWeek 2024.
A seven-day course of antibiotics for hospitalized patients with bloodstream infections is just as effective as a 14-day course, according to new findings presented at IDWeek 2024.
Bird flu was detected in wastewater before the first reported outbreak among Texas dairy cattle in 2024, according to new findings presented at IDWeek 2024.
A new method for prescribing antibiotics improved compliance with treatment guidelines and shortened antibiotic use in children with ear infections in emergency and urgent care settings, according to new findings presented at IDWeek 2024.
A gene that enables bacteria to evade treatment was the most common and deadly among carbapenemase-producing organism (CPO) infections in a New York health system, according to new findings presented at IDWeek 2024.
Black, Hispanic and Medicaid-insured populations continue to lack equitable access to pre-exposure prophylaxis, according to new findings from Gilead Sciences presented at IDWeek 2024.
The Infectious Diseases Society of America has released guidelines suggesting the use of pemivibart to prevent severe COVID-19 in immunocompromised patients.
The Senate FY 2025 Labor, Health and Human Services and the State and Foreign Operations appropriations bills provide increased funding for some key domestic and global infectious diseases programs.
The eight awarded institutions have created stewardship programs led by infectious diseases-trained physicians and pharmacists that advance science in antimicrobial resistance.
Trish Perl, MD, FIDSA, spoke on behalf of the Infectious Diseases Society of America at Thursday’s House Budget Committee roundtable on the threats of antimicrobial resistance.
The House FY 2025 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund antimicrobial resistance programs at FY 2024 levels even as AMR grows as a serious public health threat.